Empowering Access to Life-Changing Medicine For All

That's why we equip pharma access teams with the data and tools they need to navigate complex payer landscapes and optimize strategy.
0%

of all FDA-approved drugs in 2024 were launched with us

0+

Launches & label expansions

0+

Years of agency experience as an AOR

Who We Help

We span the commercialization journey, from real-world data research to patient communications.

market access

Value & Access

Generating HEOR evidence, payer strategy and payer marketing to navigate payer complexities to optimize commercial success

medical communications

Medical Communications

Craft clear, impactful messages from complex medical science for peer-to-peer audiences and KOLs

investor relations

Investor Relations & External Communications

Facilitate engaging with financial community and reaching financial goals

marketing branding PR

Brand Strategy & Marketing

Navigate category complexities through building your market strategies, brand identify, and enhancing your market presence with payers, providers, and patients

strategy research

Data, Insights, & Analytics

Understand the existing treatment landscape and maximize impact

product solutions

Product Offerings

Power HCP, payer, & patient engagement with products that evaluate market potential, streamline targeting and support commercial impact

A professional woman in a suit set against an iteration of the Precision AQ logo

Careers

Discover a career where your work profoundly impacts healthcare and improves lives. At Precision AQ, your expertise contributes to groundbreaking solutions in a culture of innovation and empathy. Join us in advancing healthcare access and outcomes.

Latest news & insights

GettyImages-1091918678-Woman_Conference_Room-RET-1
Report

The C-Suite’s Guide to Integrated Communications: Shaping the Future of Biotech and Pharma Business Strategy

Learn why leading biotech and pharma organizations are embracing an integrated IREC model: a unified approach that aligns investor relations and external messaging to build trust, drive valuation, and accelerate growth.

Oct 7, 2025

PrecAQ_IREC_blog_09222025_DosDontsBiotchInvstrs
Blog

The Do’s and Don’ts of Biotech Investor Relations and PR

Essential dos and don’ts for biotech companies navigating investor relations, with strategic guidance to build trust, manage expectations, and drive long-term value.

Nov 5, 2025

PrecAQ_AGHCPSurvey_blog_08152025_C
Infographic

What HCPs Really Think About Market Access in 2025

What do HCPs really want when it comes to market access? We surveyed 100+ providers across specialties to find out, and uncovered five key trends shaping their prescribing decisions in 2025.

Aug 25, 2025

How can Precision AQ help you?

Fields marked with an asterisk (*) are required. Please ensure all required information is provided before proceeding.